Approach to Neonatal Fever in the Pediatric Emergency Department

cocukacil-5-1-2024

Orkun AYDINa , Betül ÖZTÜRKa , Nilden TUYGUNa

aAnkara Etlik City Hospital, Clinic of Pediatric Emergency, Ankara, Türkiye

ABSTRACT
Neonatal infections are an important cause of morbidity and mortality in the first month of life, especially in developing countries. Despite the developments in the field of neonatology, the clinical significance of neonatal infections continues to be important due to the lack of specific signs and symptoms, the lack of a perfect diagnostic marker and the confusion with non-infectious clinical pictures of the neonatal period. The diagnosis is made by evaluating clinical and laboratory findings together. Empirical antibiotic treatment should be initiated in the infant with signs and symptoms suggestive of infection as soon as culture samples are obtained, based on the time of onset of the signs and symptoms, the environment where the agent was acquired and information about the focus of infection, if any, according to possible agents and risks and possible antibiotic susceptibility, and treatment change should be planned in the light of culture results, clinical observation and repeated laboratory tests when necessary. In order to prevent infections, intrapartum prophylaxis, hand washing, use of aseptic techniques in interventions, appropriate design of the intensive care unit, isolation measures and especially the use of breast milk are important. The use of diagnosis and treatment protocols increases success.
Keywords: Neonatal sepsis; meningitis; fever

Referanslar

  1. Byington CL, Enriquez FR, Hoff C, Tuohy R, Taggart EW, Hillyard DR, et al. Serious bacterial infections in febrile infants 1 to 90 days old with and without viral infections. Pediatrics. 2004;113(6):1662-6. [Crossref]  [PubMed]
  2. Caviness AC, Demmler GJ, Almendarez Y, Selwyn B. The prevalence of neonatal herpes simplex virus infection compared with serious bacterial illness in hospitalized neonates. The Journal of pediatrics. 2008;153(2):164-9. [Crossref]  [PubMed]
  3. Blaschke AJ, Korgenski EK, Wilkes J, Presson AP, Thorell EA, Pavia AT, et al. Rhinovirus in febrile infants and risk of bacterial infection. Pediatrics. 2018;141(2). [Crossref]  [PubMed]  [PMC]
  4. Sarna M, Ware RS, Lambert SB, Sloots TP, Nissen MD, Grimwood K. Timing of first respiratory virus detections in infants: a community-based birth cohort study. The Journal of infectious diseases. 2018;217(3):418-27. [Crossref]  [PubMed]  [PMC]
  5. Baker MD, Bell LM. Unpredictability of serious bacterial illness in febrile infants from birth to 1 month of age. Archives of pediatrics & adolescent medicine. 1999;153(5):508-11. [Crossref]
  6. Kadish HA, Loveridget B, Tobeyt J, Bolte RG, Corneli HM. Applying outpatient protocols in febrile infants 1-28 days of age: can the threshold be lowered? Clinical pediatrics. 2000;39(2):81-8. [Crossref]  [PubMed]
  7. Maniaci V, Dauber A, Weiss S, Nylen E, Becker KL, Bachur R. Procalcitonin in young febrile infants for the detection of serious bacterial infections. Pediatrics. 2008;122(4):701-10. [Crossref]  [PubMed]
  8. Hui C, Neto G, Tsertsvadze A, Yazdi F, Tricco AC, Tsouros S, et al. Diagnosis and management of febrile infants (0-3 months). Evidence report/technology assessment. 2012;(205):1-297.
  9. Garcia S, Mintegi S, Gomez B, Barron J, Pinedo M, Barcena N, et al. Is 15 days an appropriate cut-off age for considering serious bacterial infection in the management of febrile infants? The Pediatric infectious disease journal. 2012;31(5):455-8. [Crossref]  [PubMed]
  10. Pantell RH, Roberts KB, Adams WG, Dreyer BP, Kuppermann N, O'Leary ST, et al. Clinical practice guideline: evaluation and management of Well-Appearing febrile infants 8 to 60 days old. Pediatrics. 2021;148(2). [Crossref]  [PubMed]
  11. Baraff LJ, Schriger DL, Bass JW, Fleisher GR, Klein JO, McCracken Jr GH, et al. Practice guideline for the management of infants and children 0 to 36 months of age with fever without source. Pediatrics. 1993;92(1):1-12. [Crossref]
  12. Pantell RH, Newman TB, Bernzweig J, Bergman DA, Takayama JI, Segal M, et al. Management and outcomes of care of fever in early infancy. Jama. 2004;291(10):1203-12. [Crossref]  [PubMed]
  13. Gomez B, Mintegi S, Bressan S, Da Dalt L, Gervaix A, Lacroix L. Validation of the "step-by-step" approach in the management of young febrile infants. Pediatrics. 2016;138(2). [Crossref]  [PubMed]
  14. Bachur RG, Harper MB. Predictive model for serious bacterial infections among infants younger than 3 months of age. Pediatrics. 2001;108(2):311-6. [Crossref]  [PubMed]
  15. Powell EC, Mahajan PV, Roosevelt G, Hoyle Jr JD, Gattu R, Cruz AT, et al. Epidemiology of bacteremia in febrile infants aged 60 days and younger. Annals of emergency medicine. 2018;71(2):211-6. [Crossref]  [PubMed]  [PMC]
  16. Mah V, Vanderkooi OG, Johnson DW. Epidemiology of Serious Bacterial Infections in Infants Less Than 90 Days of Age, Presenting to a Tertiary Care Emergency Department, 2010 to 2016. The Pediatric infectious disease journal. 2019;38(7):e161-e3. [Crossref]  [PubMed]
  17. Byington CL, Rittichier KK, Bassett KE, Castillo H, Glasgow TS, Daly J, et al. Serious bacterial infections in febrile infants younger than 90 days of age: the importance of ampicillin-resistant pathogens. Pediatrics. 2003;111(5):964-8. [Crossref]  [PubMed]
  18. Leazer R, Perkins AM, Shomaker K, Fine B. A meta-analysis of the rates of Listeria monocytogenes and Enterococcus in febrile infants. Hospital Pediatrics. 2016;6(4):187-95. [Crossref]  [PubMed]
  19. Torrey S, Fleisher G, Jaffe D. Incidence of Salmonella bacteremia in infants with Salmonella gastroenteritis. The Journal of pediatrics. 1986;108(5):718-21. [Crossref]  [PubMed]
  20. Wittler RR, Bass JW. Nontyphoidal Salmonella enteric infections and bacteremia. The Pediatric infectious disease journal. 1989;8(6):364-7. [Crossref]  [PubMed]
  21. Baker MD, Avner JR, Bell LM. Failure of infant observation scales in detecting serious illness in febrile, 4-to 8-week-old infants. Pediatrics. 1990;85(6):1040-3. [Crossref]  [PubMed]
  22. Nigrovic LE, Mahajan PV, Blumberg SM, Browne LR, Linakis JG, Ruddy RM, et al. The Yale observation scale score and the risk of serious bacterial infections in febrile infants. Pediatrics. 2017;140(1). [Crossref]  [PubMed]  [PMC]
  23. Bonadio WA, Hennes H, Smith D, Ruffing R, Melzer-Lange M, LYE P, et al. Reliability of observation variables in distinguishing infectious outcome of febrile young infants. The Pediatric infectious disease journal. 1993;12(2):111-4. [Crossref]  [PubMed]
  24. Yarden-Bilavsky H, Ashkenazi-Hoffnung L, Livni G, Amir J, Bilavsky E. Month-by-month age analysis of the risk for serious bacterial infections in febrile infants with bronchiolitis. Clinical pediatrics. 2011;50(11):1052-6. [Crossref]  [PubMed]
  25. Rostad BS, Shah JH, Rostad CA, Jaggi P, Richer EJ, Linam LE, et al. Chest radiograph features of multisystem inflammatory syndrome in children (MIS-C) compared to pediatric COVID-19. Pediatric radiology. 2021;51:231-8. [Crossref]  [PubMed]  [PMC]
  26. Bonadio W, Huang F, Natesan S, Okpalaji C, Kodsi A, Sokolovsky S, et al. Meta-analysis to determine risk for serious bacterial infection in febrile outpatient neonates with RSV infection. Pediatric emergency care. 2016;32(5):286-9. [Crossref]  [PubMed]
  27. Payson A, Etinger V, Napky P, Montarroyos S, Ruiz-Castaneda A, Mestre M. Risk of serious bacterial infections in young febrile infants with COVID-19. Pediatric Emergency Care. 2021;37(4):232-6. [Crossref]  [PubMed]
  28. Jamehdar SA, Mammouri G, Hoseini MRS, Nomani H, Afzalaghaee M, Boskabadi H, et al. Herpes simplex virus infection in neonates and young infants with sepsis. Iranian Red Crescent Medical Journal. 2014;16(2). [Crossref]  [PubMed]  [PMC]
  29. Greenhow TL, Hung Y-Y, Herz AM. Changing epidemiology of bacteremia in infants aged 1 week to 3 months. Pediatrics. 2012;129(3):e590-e6. [Crossref]  [PubMed]
  30. Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. The Lancet. 2020;395(10219):200-11. [Crossref]  [PubMed]
  31. Mahajan P, Browne LR, Levine DA, Cohen DM, Gattu R, Linakis JG, et al. Risk of bacterial coinfections in febrile infants 60 days old and younger with documented viral infections. The Journal of pediatrics. 2018;203:86-91. e2. [Crossref]  [PubMed]  [PMC]